Since tumors are possible sources for inflammatory cytokines like IL-6 and TNF-α, analyses were repeated after excluding 8 patients who developed cancers within one year from baseline, to reduce the effect of a preclinical malignancy. The gene discussed is TNF; the disease is cancer.